Skip to content

Investors & Media


Data Provided by Refinitiv.
Minimum 15 minutes delayed.

lnk Stock Information

Learn More

Creating value by saving sight through transformative science.

Press Releases

17-Feb-21

Graybug Vision to Participate in SVB Leerink Global Healthcare Conference

REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced that Fred Guerard,

01-Feb-21

Corporate Statement: Graybug Vision Joins CEO Action for Diversity and Inclusionᵀᴹ

Corporate Statement Graybug Vision Joins CEO Action for Diversity and Inclusion TM I am proud to announce that Graybug is taking an action-oriented step, together with more than 1,500 businesses in the U.S., to advance diversity and inclusion in our workplace, communities and society.

01-Feb-21

Graybug Vision Appoints Bettina Maunz as Chief People Officer, Expanding the Company’s Executive Team

REDWOOD CITY, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the appointment of

lnk News

View All News

Connect with Us
Sign up for ongoing news and events.
Font Resize